Neuropore Therapies, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2008-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.neuropore.com
Clinical Trials
2
Active:0
Completed:2
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)A Study to Assess the Safety, Tolerability and PK of NPT520-34 in Healthy Subjects
Phase 1
Completed
- Conditions
- Healthy Volunteers
- Interventions
- Drug: Placebos (125 mg)
- First Posted Date
- 2019-05-17
- Last Posted Date
- 2020-01-13
- Lead Sponsor
- Neuropore Therapies Inc.
- Target Recruit Count
- 49
- Registration Number
- NCT03954600
- Locations
- 🇺🇸
Celerion, Inc, Tempe, Arizona, United States
Phase 1 Study of NPT200-11 in Healthy Subjects
- First Posted Date
- 2015-11-17
- Last Posted Date
- 2016-02-15
- Lead Sponsor
- Neuropore Therapies Inc.
- Target Recruit Count
- 55
- Registration Number
- NCT02606682
- Locations
- 🇺🇸
Celerion, Inc, Tempe, Arizona, United States
News
No news found